ジュウジョウ ケンタロウ
JUJO Kentaro
重城 健太郎 所属 埼玉医科大学 医学部 総合医療センター 心臓内科 職種 教授 |
|
論文種別 | 学術雑誌(原著) |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women |
掲載誌名 | 正式名:HEART ISSNコード:13556037 |
出版社 | BMJ PUBLISHING GROUP |
巻・号・頁 | 103(17),1368-1373頁 |
著者・共著者 | Haruki Sekiguchi,Ken Shimamoto,Mayu Takano,Makiko Kimura,Yufuko Takahashi,Fujio Tatsumi,Eri Watanabe,Kentaro Jujo,Naoko Ishizuka,Masatoshi Kawana,Nobuhisa Hagiwara |
発行年月 | 2017/09 |
概要 | Objective Plasma cancer antigen (CA)-125 is a tumour marker recently shown to be associated with systolic heart failure and new-onset atrial fibrillation (AF) after myocardial infarction. However, no reports have described the relationship between CA-125 and new-onset AF in healthy postmenopausal women. The aim of the present study was to evaluate the relationship between CA-125 and new-onset AF in postmenopausal women.Methods Between 2005 and 2015, 2086 women, including 1012 postmenopausal women, visited our hospital for annual health check-ups. We excluded patients with systolic dysfunction, chronic inflammatory disease, chronic obstructive pulmonary disease, histories of AF or neoplastic diseases. A total of 746 postmenopausal women underwent thorough physical examinations, including those for biomarkers such as brain natriuretic peptide, high-sensitivity C-reactive protein (hs-CRP) and CA-125.Results During the 10-year observation period, AF was documented in 31 participants (4.2%). The mean age of participants developing AF (75 +/- 6 years) was higher than that of those without AF (68 +/- 8 years). Participants developing AF showed significantly higher CA-125 (11.4 +/- 6.3 U |
DOI | 10.1136/heartjnl-2016-310272 |